Prediction and prevention of type 1 diabetes mellitus: initial results and recent prospects

Orvosi hetilap
László Madácsy

Abstract

Epidemiological studies indicate that the incidence and prevalence of type 1 diabetes mellitus is rising worldwide. The increase in incidence has been most prominent in the youngest age group of childhood. Prediction of type 1a autoimmune diabetes can be established by a positive family history or by genetic, immunological or metabolic markers. Prevention of type 1 diabetes can be implemented at three different levels of pathogenesis: primary prevention in individuals without any sign of beta-cell damage, secondary prevention in individuals with signs of beta-cell destruction and tertiary prevention in patients with newly diagnosed type 1 diabetes. In recent years our knowledge of the disease pathogenesis has grown quickly, and several new prevention trials have been initiated worldwide. Immunologic intervention for type 1 diabetes will prove to be probably the most effective.

References

Feb 1, 1990·Diabetic Medicine : a Journal of the British Diabetic Association·Gyula SoltészI Dankó
May 31, 2002·The New England Journal of Medicine·Diabetes Prevention Trial--Type 1 Diabetes Study Group
Jul 13, 2002·American Journal of Medical Genetics·H K AkerblomMikael Knip
Mar 1, 2003·Clinics in Geriatric Medicine·S H Tariq
Dec 12, 2003·The American Journal of Clinical Nutrition·S M Virtanen, Mikael Knip
Mar 16, 2004·Pediatric Diabetes·Eva GyürüsHungarian Childhood Diabetes Epidemiology Study Group
Mar 27, 2004·Lancet·E A M GaleEuropean Nicotinamide Diabetes Intervention Trial (ENDIT) Group
Jul 21, 2007·Nature Reviews. Immunology·Lucienne Chatenoud, Jeffrey A Bluestone
Oct 19, 2007·Proceedings of the National Academy of Sciences of the United States of America·Janet M WenzlauJohn C Hutton
Jan 29, 2008·Pediatric Diabetes·Scott SlokaLeigh Anne Newhook
Apr 18, 2008·Pediatric Diabetes·Klaus Badenhoop
Jan 6, 2009·Annals of the New York Academy of Sciences·Rita BortellAldo A Rossini
May 16, 2009·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Kevan HeroldImmune Tolerance Network ITN007AI Study Group
Nov 27, 2009·The New England Journal of Medicine·Mark D PescovitzType 1 Diabetes TrialNet Anti-CD20 Study Group
Dec 1, 2009·Endocrinology and Metabolism Clinics of North America·Diane K Wherrett, Denis Daneman
Oct 12, 2010·Diabetes/metabolism Research and Reviews·S CerneaItamar Raz
Nov 16, 2010·Journal of Diabetes·Li Zhang, George S Eisenbarth
Jul 5, 2011·British Medical Bulletin·S L Thrower, P J Bingley

Citations

Sep 24, 2015·Pediatric Diabetes·Colette MeehanMichael J Haller

Related Concepts

Autoantibodies
Diabetes, Autoimmune
Enterovirus Infections
Intravenous Glucose Tolerance Test
HLA-DQ Antigens
HLA-DR Antigens
Hypoglycemic Effect
Immunosuppressive Agents
Novolin
Niacin Manganese (2+) Salt

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Related Papers

Diabetes/metabolism Research and Reviews
S CerneaItamar Raz
Pediatric Clinics of North America
Diane K Wherrett, Denis Daneman
Clinical and Experimental Immunology
Matthias G Von HerrathB Roep
© 2021 Meta ULC. All rights reserved